Seed Therapeutics Employee Directory

Seed Therapeutics corporate office is located in 411 Swedeland Rd Ste 1000, King of Prussia, Pennsylvania, 19406, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

3

Finance

2

Operations

2

C-Suite

1

Human Resources

1

Key Employees of Seed Therapeutics

  • James Tonra, President & Chief Scientific Officer at Seed Therapeutics
    United States flag for contact location.
    James Tonra

    President & Chief Scientific Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Seed Therapeutics Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Seed Therapeutics

Hundreds of professionals searching for Seed Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Seed Therapeutics

Explore people who held key positions, contributed to Seed Therapeutics's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Pennsylvania, United States

Frequently Asked Questions Regarding Seed Therapeutics Employees

How many employees does Seed Therapeutics have?
Seed Therapeutics has 11-50 employees
Who are Seed Therapeutics key employees?
Some of Seed Therapeutics key employees are James Tonra
Where is Seed Therapeutics located?
Seed Therapeutics’s headquarters are located at 411 Swedeland Rd Ste 1000, King of Prussia, Pennsylvania, 19406, United States
How do I contact Seed Therapeutics?
Seed Therapeutics Contact Info: Phone number: (646) 305-6387 Website: www.seedtherapeutics.com
What does Seed Therapeutics do?

SEED Therapeutics specializes in designing molecular glue degraders that utilize the full E3 ligase universe to target and eliminate disease proteins, particularly in oncology. Their innovative RITE3 platform enables the identification of optimal ligase-target pairs, allowing for a more precise approach to targeted protein degradation. The company... is currently advancing its lead product, ST-01156, through Phase 1 trials for various tumors, supported by strategic partnerships with industry leaders like Lilly and Eisai. SEED Therapeutics aims to make a significant impact on patient care by developing therapies for diseases where traditional treatments have failed.Read More

Is Seed Therapeutics a public company?
Seed Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Seed Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.